Advanced Diffusion Imaging in Renal Cancer Patients

Description

The objective of this study is to apply advanced diffusion imaging in a two-pronged assessment of renal mass patients: (1) characterization of lesion malignancy and subtype, and (2) prediction of renal function stability or decline following partial nephrectomy.

Conditions

Renal Cancer

Talk to us

Study Overview

On this page

Study Details

Study overview

The objective of this study is to apply advanced diffusion imaging in a two-pronged assessment of renal mass patients: (1) characterization of lesion malignancy and subtype, and (2) prediction of renal function stability or decline following partial nephrectomy.

Advanced Diffusion Imaging in Renal Cancer Patients: Oncologic Control and Renal Functional Reserve

Advanced Diffusion Imaging in Renal Cancer Patients

Condition
Renal Cancer
Intervention / Treatment

-

Contacts and Locations

New York

NYU Langone Health, New York, New York, United States, 10016

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Renal mass patients scheduled for laparoscopic partial nephrectomy.
  • * eGFR above 30 ml/min/m2.
  • * Ages 21 to 85
  • * Must be willing and able to provide consent.
  • * All metal implants and dental implants that have ferromagnetic properties and are unsafe at 3.0 T.
  • * Pregnant women are not eligible for participating in this study.
  • * Acute claustrophobia

Ages Eligible for Study

21 Years to 85 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

NYU Langone Health,

Eric Sigmund, PhD, PRINCIPAL_INVESTIGATOR, NYU Langone Medical Center

Study Record Dates

2028-12-01